期刊
MOLECULAR CELL
卷 71, 期 4, 页码 554-+出版社
CELL PRESS
DOI: 10.1016/j.molcel.2018.06.040
关键词
-
资金
- Prostate Cancer Foundation
- NIH/NCI [U01 CA176058]
- Department of Defense Prostate Cancer Research Program Postdoctoral Training Award [W81XWH-15-1-0659]
- NIH/NCI Tumor Cell Biology Training Program Grant [T32-CA009361]
- Department of Defense Prostate Cancer Research Program Idea Development Award [W81XWH-15-1-0546]
- NIH [UH2 CA213392]
- NIH DP2 New Innovator Award [1DP2CA195762-01]
- American Cancer Society Research Scholar Award [RSG-14-051-01-DMC]
- Pew-Stewart Scholars in Cancer Research Grant
Chromosomal rearrangements resulting in the fusion of TMPRSS2, an androgen-regulated gene, and the ETS family transcription factor ERG occur in over half of prostate cancers. However, the mechanism by which ERG promotes oncogenic gene expression and proliferation remains incompletely understood. Here, we identify a binding interaction between ERG and the mammalian SWI/SNF (BAF) ATP-dependent chromatin remodeling complex, which is conserved among other oncogenic ETS factors, including ETV1, ETV4, and ETV5. We find that ERG drives genome-wide retargeting of BAF complexes in a manner dependent on binding of ERG to the ETS DNA motif. Moreover, ERG requires intact BAF complexes for chromatin occupancy and BAF complex ATPase activity for target gene regulation. In a prostate organoid model, BAF complexes are required for ERG-mediated basal-to-luminal transition, a hallmark of ERG activity in prostate cancer. These observations suggest a fundamental interdependence between ETS transcription factors and BAF chromatin remodeling complexes in cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据